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ABSTRACT 
Objective: Infections of the urinary tract remains one of the most common bacterial infections with many implicated organisms being Gram-negative, 
which are increasingly resistant to antimicrobial agents. The aim of the study was to evaluate the resistance of ESBL producing Gram-negative 
enterobacteriaceae to commonly prescribed antibiotics and the prevalence of CTX-M genes from these isolates using polymerase chain reaction (PCR). 
Methods: The isolates were collected from urine over a period of 4 mo and studied, and were identified using Microgen Identification Kit (GN-ID). 
Susceptibility testing was performed by the modified Kirby Bauer disc diffusion method, and results were interpreted according to Clinical and 
Laboratory Standard Institute (CLSI). Extended-Spectrum Beta-Lactamase (ESBL) production was detected by the double-disc synergy test (DDST). 
Molecular characterization was based on the isolates that were positive for the phenotypic detection of ESBL. 
Results: Sixty one (61) isolates of Gram-negative uropathogens were identified. Of these, 19 (31.2%) were E. coli, 15 (24.6%) were Salmonella 
arizonae, Klebsiella pneumoniae were 7 (11.5%), Klebsiella oxytoca were 3 (4.9%), Enterobacter gergoviae were 6 (9.8%), 4 (6.6%) were Citrobacter 
freundii, 4 (6.6%) were Serratia marscence, and 1 (1.6%) were Enterobacter aerogenes, Proteus mirabilis, and Edwardsiella tarda each. Analysis of 
the bacterial susceptibility to antibiotics revealed most of them to be generally resistant to cotrimoxazole (73.3%), nalidixic acid (66.7%), 
norfloxacin (53.5%), ciprofloxacin (50.5%), gentamicin (48.6%), amoxicillin/clavulanate (45%), and the least resistant was displayed in 
nitrofurantoin (30%). Of the 15 ESBL producers, 11 (73.3%) were harbouring bla CTX-M genes.  
Conclusion: The study revealed a high susceptibility to nitrofurantoin, whereas susceptibility to cotrimoxazole was lowest. It further portrays a 
high prevalence of enterobacteriaceae isolates harbouring bla CTX-M genes in Sokoto metropolis. 
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INTRODUCTION 
Urinary Tract Infections (UTIs) are a serious public health issue, 
particularly in the developing world where there is a high level of 
poverty, ignorance and poor hygienic practices [1]. UTIs are the 
most prevalent bacterial infections in humans with Gram-negative 
pathogens most especially E. coli, which is regarded as the most 
important cause of nosocomial infections [2], both in adults as well 
as pediatric groups [3]. 
Wagenlehner and Naber [4] (2006) further noted that there are two 
important aims in the antimicrobial treatment of UTIs; an effective 
rapid response to therapy and prevention of recurrence of the 
patient treated and prevention of emergence of resistance to 
antimicrobial chemotherapy.  
Since antibiotics have been introduced into clinical medicine, 
antibiotic-resistant bacteria have evolved. In 2016, the World Health 
Organization officially stated that “antimicrobial resistance is a 
global and societal challenge and threat”. The constant increase of 
simultaneous resistance to various classes of antibiotics significantly 
reduces the possibility of treatment of infections caused by ESBL 
producers [5-7] have also reported that the management of UTIs has 
become increasingly challenging due to the production of ESBLs. 
They tend to be a worrying global public health issue due to their 
associated higher morbidity and mortality. Hence, they represent a 
clear and present higher danger to public health [8]. 
The production of ESBLs is one of the most prevalent resistance 
mechanisms in Gram-negative bacilli. ESBLs are enzymes whose 
rates of hydrolysis of the extended-spectrum beta-lactam antibiotics 
such as ceftazidime, cefotaxime, or aztreonam are>10% than that for 
benzylpenicillin [9]. ESBLs are predominantly described in K. 
pneumoniae and E. coli, but recently the enzymes were found in 
other genera of Enterobacteriaceae family [6, 10].  
Initially, the Temoneira (TEM) and sulphydryl variants (SHV) were 
recognized as the main ESBLs, but in recent times, the cefotaximase-
Munich (CTX-M) become more prominent and considered the most 
prevalent beta-lactamases found in clinical isolates of E. coli globally [11]. 
Currently, the three major ESBL types are TEM, SHV, and CTX-M [9].  
There are reported cases of CTX-M producing uropathogens isolates 
[12], and in orthopedic patients [13] from Nigeria. The CTX-M 
enzymes are known as an increasingly serious public health concern 
worldwide and have been noted to be the cause of outbreaks 
throughout the world [14]. These CTX-M genes are usually present 
in large plasmids that also carry additional resistance genes, but 
have been found on plasmids ranging in size from 7 to 430 kb [9].  
The ongoing global spread and increased prevalence of CTX-M-type 
ESBL in Enterobacteriaceae is of great concern [15]. Due to the 
explosive dissemination of CTX-M around the world and increasing 
description worldwide, Canton et al., [16] have referred to it as the 
“CTX-M pandemic”.  
The study evaluates the resistance of the ESBL producing Gram-negative 
Enterobacteriaceae to commonly prescribed antibiotics and investigates 
the prevalence of CTX-M genes from these isolates using PCR.  
MATERIALS AND METHODS 
Approval to carry out this study was obtained from the ethics 
committee of the Specialist Hospital Sokoto (SHS) with approval 
number ESHS/239839. The sample collection was based on 
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informed consent. The study was carried out in the Pharmaceutical 
Microbiology Laboratory of Department of Pharmaceutics and 
Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, 
Usmanu Danfodiyo University, Sokoto. 
Chemicals and reagents 
The culture media and antibiotic discs used in this study were all 
sourced from Oxoid, UK and prepared as per the manufacturer’s 
instruction. Identification kit used is sourced from Microgen ID Kit, 
GN-ID, UK, while the plasmid extraction kit is from ZymoPURE™, and 
primers were sourced from Inqaba Biotech, South Africa.  
Inclusion criteria 
Included in the study were urine samples from outpatients with 
UTIs with age group ≥ 18 y. A UTI in this study was defined as a 
positive urine culture ≥ 108 
A suspension of each test organism was prepared in freshly prepared 0.9 
% normal saline to give an inoculum equivalent to a 0.5 McFarland. The 
test organisms were inoculated on the surface of MHA plates. 
Confirmation of the ESBL phenotype was performed by DDST using 
antibiotic discs containing two cephalosporins and amoxicillin/ 
clavulanate. The discs were ceftazidime, CAZ (30 µg), AMC (30 µg) and 
cefotaxime, CTX (30 µg). A sterile needle was used to place the CTX and 
CAZ on the agar at a distance of 20 mm center to center from a 
combination disc of AMC. The plates were incubated at 37 °C and were 
examined for an extension of the edge of the zone of inhibition of 
antibiotic discs towards the disc containing AMC. It is interpreted as 
synergy and considered positive or the presence of ESBL.  
E. coli ATCC 25922 and K. pneumoniae ATCC 700603 strains were 
used as negative and positive control respectively in this study. 
Bacteria cell preparation 
Luria and Bertani (LB) broth was used, which is a rich medium that 
is commonly used to culture members of the Enterobacteriaceae or 
as a general-purpose bacterial culture medium for a variety of 
facultative organisms. Single colonies were picked from freshly 
streaked isolates on NA and inoculated into 5 ml LB broth medium 
and incubated overnight at 37 °C. Bacterial cells were then 
harvested by centrifugation at 4 °C, 16,000 rpm in a refrigerated 
micro-centrifuge for 30 seconds at 37 °C in an Eppendorff’s tube. 
The supernatant was then decanted and cells harvested.  
Plasmid extraction 
Plasmid extraction was carried out using ZymoPURE
colony-forming unit/milliliters (cfu/ml) 
of pure bacterial growth. 
Collection of clinical isolates 
A total of three hundred and sixty-five (365) non-repetitive urine 
samples were collected over four (4) months from patients. Early 
morning mid-stream clean catch urine samples were collected by 
patients in sterile disposable containers. Before urine collection, 
patients were counseled on how to collect urine samples by observing 
all aseptic conditions to avoid contamination. Urine samples were 
inoculated on Cysteine Lactose Electrolyte Deficient (CLED) agar using 
a calibrated wire loop and incubated under aerobic conditions for 18-
24 h at 37 °C Pure cultures of the individual isolates were obtained by 
sub-culturing on nutrient agar (NA). 
Identification of bacterial isolates  
An 18-24 hour pure culture of the bacterial isolate to be identified was 
used. Oxidase test was carried out on the isolate before strip inoculation. 
Only oxidase negative isolates were considered. A loopful was emulsified 
from an 18-24 hour culture in 3 ml sterile 0.9 % saline for the GN A 
microwell strip (Microgen Identification Kit) and was mixed thoroughly. 
Using a sterile Pasteur pipette, 3-4 drops (approximately 100μl) of the 
bacterial suspension was added to each well of the strip(s). The GN A 
microwell strips were read after 18-24 h incubation for 
Enterobacteriaceae according to manufacturer’s instruction. 
Antibiotic susceptibility testing (AST) 
The susceptibility of the isolates to seven (7) commonly prescribed 
antibiotics was determined by the modified Kirby Bauer disc agar 
diffusion on Mueller Hinton agar (MHA). The antibiotic used were 
ciprofloxacin (CIP, 5 µg), norfloxacin (NOR, 10 µg), gentamicin (CN, 
30 µg), nalidixic acid (NA, 30 µg), cotrimoxazole (SXT, 25 µg), 
nitrofurantoin (F, 300 µg), and amoxicillin/clavulanic acid (AMC, 30 
µg). Results were interpreted according to CLSI guidelines [17].  
Screening for ESBL production 
Multidrug-resistant (MDR) isolates were further screened for ESBL 
production. ESBL screening was performed by disc diffusion using 
cefotaxime (CTX, 30µg) and ceftazidime (CAZ, 30µg) on MHA for the 
initial screening test. The tests were interpreted according to CLSI 
guidelines. 
The zones in mm shown below for respective antibiotics indicate 
potential ESBL producers. 
cefotaxime (CTX) ≤ 27 
ceftazidime (CAZ) ≤ 22 
For any isolate that is suspected as an ESBL producer, a phenotypic 
confirmatory test was carried out. 
Phenotypic confirmatory test for ESBL production 
TM Plasmid 
Miniprep Kit according to the manufacturer’s instructions. To 
ascertain that plasmids were extracted, the extracted plasmids were 
subjected to agarose gel electrophoresis. 
Amplification of CTX-M genes 
Amplification of plasmid DNA fragments was carried out using 
Dream TaqTMDNA polymerase (enhanced Taq DNA Polymerase 
optimized for high throughput PCR applications). Dream TaqTMPCR 
master mix (2X) was vortexed and centrifuged for 30 seconds at 
8,000 rpm. The thin-walled PCR tube was then placed on an ice pack 
and the following components were added for each isolate for the 
single reaction of 10 µl viz: 0.2 µl of Dream TaqTM PCR master mix 
was added in the PCR tube. Then dNTP Mix 2 mmol each 0.5 µl were 
added, forward primers; CTX-M 0.5 µl of the forward primers were 
calculated and added. Then 0.5 µl CTX-M of the reverse primers 
were calculated and added. A 3.0 µl of template DNA (plasmid DNA), 
10X PCR Taq buffer 1 µl were added. The nuclease-free water was 
added in the PCR tube to make up a total volume of 10 µl. The 
samples were vortexed gently and spin down. For 15 isolates, the 
forward and reverse primers, Taq buffer, dNTP, Taq polymerase, 
water, and template were multiplied by 15, making a total sum of 
150 µl Dream TaqTM
RESULTS 
 PCR master mix (2X) i.e. for forwarding 7.5 µl 
CTX-M, and reverse primer: 7.5 µl CTX-M. 
Primers and conditions used for PCR 
PCR was performed with the primers used in this study, as shown in 
table 1, and the thermal cycling conditions as shown in table 2. 
Detection of PCR products on agarose gel  
A 2% agarose gel was used to resolve the PCR plasmid DNA 
fragments with their primers. The amplicons were separated using 
electrophoresis and photographed under ultraviolet illuminator 
using a gel documentation system (BIORAD, USA).  
Statistical analysis 
Data were analyzed using Microsoft Excel. 
Three hundred and sixty-five (365) urine samples were analyzed 
over 4 mo period. After the investigations, the results showed that 
the percentage of Gram-negative isolates was 16.7%. The prevalence 
of isolates in females was 42 (68.8%) and in males 19 (31.2%). The 
Gram-negative isolates consist mainly of E. coli (31.1%), Salmonella 
arizonae 24.6%, Klebsiella oxytoca 4.9%, Klebsiella pneumoniae 
11.5%, Enterobacter gergoviae 9.8%, Citrobacter freundii 6.6%, 
Serratia marscence 6.6%, and 1.6% were Enterobacter aerogenes, 
Proteus mirabilis, and Edwardsiella tarda each. The percentage 
distribution of the Gram-negative isolates is shown in fig. 1. 
Nuhu et al. 
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Table 1: Primers used in this study 
Gene  Size (bp) Nucleotide sequence (5’-3’) Annealing T °C Reference 




Table 2: Thermal cycling conditions for PCR 
Step Temperature °C Time No. of cycles 
Initial denaturation 94 3 min 1 
Denaturation  94 15 seconds 30 
Annealing  65 30 seconds 1 
Extension  72 30 seconds 1 
Final extension 72 5 min 1 
Final hold 10   
 
Antimicrobial susceptibility testing 
The Gram-negative uropathogens were generally resistant to 
cotrimoxazole (73.3%), nalidixic acid (66.7%), norfloxacin (53.5%), 
ciprofloxacin (50.5%), and gentamicin (48.6%). The percentage 
susceptibility of the Gram-negative uropathogens is shown in fig. 2. 
Identification and screening for ESBL production in gram-
negative uropathogens 
The result of the identification and screening for ESBL production in 
Gram-negative uropathogens found that out of the 61 Gram-negative 
isolates, (18) 29.5% were potential ESBL producers, while 70.5% 
were not ESBL producers. 
Phenotypic confirmation of ESBL production in gram-negative 
uropathogens using DDST 
Upon analyzing the 18 isolates for phenotypic ESBL confirmation 
using DDST, 15 (83.3%) were confirmed ESBL producers. 
Amplification of CTX-M on gel electrophoresis 
The plasmid DNA PCR of the CTX-M gene on ESBL isolates revealed 
the position of the amplification products, which were estimated 
with the position of the molecular weight marker as shown in fig. 3. 
Eleven (11) of the 15 isolates were found in the region of the 
expected amplicon of 909 bp. 
 
 
Fig. 1: Percentage distribution of gram-negative isolates from urine 
 
 
Fig. 2: Percentage suceptibility of gram-negative uropathogens to commonly presecribed antibiotics CIP = Ciprofloxacin, NOR = 
Norfloxacin, CN = Gentamicin, NA = Nalidixic acid, SXT = Co-trimoxazole, F = Nitrofurantoin, AMC = Amoxicilli/clavulanic acid 
Nuhu et al. 




Fig. 3: Gel picture of CTX-M gene on ESBL Isolates, Eg = Enterobacter gergoviae, Al = Acintobacter iwoffi, Cf = citrobacter freundii, Sm = 
Serratia marcescens, Ec = Eschericiha coil, Kp = Klebsiella pneumonia 
 
DISCUSSION 
Although UTIs caused by ESBL producing Gram-negative 
Enterobacteriaceae are a cause of concern due to clinical failure of 
empirical treatment, the occurrence of ESBL positive strains 
expressing MDR to antibiotics has remained the dominant problem 
in the therapy of infections caused by Gram-negative bacilli [6, 19]. 
The overall frequency of ESBL producing Enterobacteriaceae among 
urinary tract pathogens in this study was 83.3%. However, in 
comparison to our study, a combination of low and high isolation 
rate was recorded in many studies: 44% in Saudi Arabia [20], 66.7% 
in India [21], 67.9% in Portugal [22], and 84% in Turkey [23].  
Our study showed isolates were resistant to the commonly used 
antibiotics such as cotrimoxazole (73.3%), nalidixic acid (66.7%), 
norfloxacin (53.3%), ciprofloxacin (50.5%), and a lesser rate in 
gentamicin (48.6%) and amoxicillin/clavulanate (45.7%) with least 
in nitrofurantoin (31.4%). A similar data is a comparison with a 
study in India, in which isolates showed high resistance to 
ampicillin, cephalosporins, quinolones, and cotrimoxazole, but 
comparatively less resistance to gentamicin, levofloxacin, 
nitrofurantoin, netilmicin and imipenem [24, 28].  
CTX-Mbeta-lactamases are often observed in clinical isolates of E. 
coli and K. pneumoniae [9]. This is in line with our study, as out of 
the 15 isolates, eleven harbor CTX-Mbeta-lactamases, with E. coli 
(33.3%), Enterobacter aerogene (13.3%), while Klebsiella 
pneumoniae, Klebsiella oxytoca, Proteus mirabilis, and Citrobacter 
freundii with 6.7% each. Rezai et al., [25] from Iran observed low 
prevalence of CTX-M (28%) and [26] reported a 28.8% prevalence of 
CTX-M. In another study, CTX-M (5.1%) gene was responsible for 
ESBL production [14]. The data are however lower to our study 
(73.3%). A similar prevalence to our study was recorded by [27], in 
which CTX-M (74%) enzymes were the most common ESBL types.  
Our study demonstrates an increasing trend in the emergence of 
ESBL in community-acquired UTI. Therefore, it is of great concern 
that the Gram-negative uropathogens carrying CTX-M are 
widespread in the Sokoto metropolis. Hence the need for 
antimicrobial stewardship and guidance for the management of 
these complex MDR infections can never be overemphasized.  
CONCLUSION 
The study revealed a high susceptibility to nitrofurantoin by the 
Gram-negative uropathogens, whereas susceptibility to 
cotrimoxazole to these isolates was lowest. It further portrays a high 
prevalence of Enterobacteriaceae isolates harboring CTX-M genes; 
thus a demonstration of the emergence of ESBL in community-
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